Exploitation of host lipids by bacteria

Current Opinion in Microbiology

Volumn 17, Issue 1, 2014, Pages 38-45

  Vromman, François ^a,b,c   Subtil, Agathe ^a,b  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID;

BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIUM; CELL MEMBRANE; CELL VACUOLE; ENZYME ACTIVITY; EUKARYOTIC CELL; HOST; INTRACELLULAR BACTERIUM; LIPID METABOLISM; NONHUMAN; REVIEW;

ANIMALS; BACTERIA; CELL MEMBRANE; HOST-PATHOGEN INTERACTIONS; HUMANS; LIPIDS; MICE;

EID: 84890021665     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2013.11.003     Document Type: Review

References (63)

1. van der Meer-Janssen Y.P.M., van Galen J., Batenburg J.J., Helms J.B. Lipids in host-pathogen interactions: pathogens exploit the complexity of the host cell lipidome. Prog Lipid Res 2010, 49:1-26.
2. Wylie J.L., Hatch G.M., McClarty G. Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis. J Bact 1997, 179:7233-7242.
3. Parsons J.B., Rock C.O. Bacterial lipids: metabolism and membrane homeostasis. Prog Lipid Res 2013, 52:249-276.
4. Layre E., Moody D.B. Lipidomic profiling of model organisms and the world's major pathogens. Biochimie 2013, 95:109-115.
5. Wunder C., Churin Y., Winau F., Warnecke D., Vieth M., Lindner B., Zahringer U., Mollenkopf H.J., Heinz E., Meyer T.F. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med 2006, 12:1030-1038.
6. Wang H.-J., Cheng W.-C., Cheng H.-H., Lai C.-H., Wang W.-C. Helicobacter pylori cholesteryl glucosides interfere with host membrane phase and affect type IV secretion system function during infection in AGS cells. Mol Microbiol 2012, 83:67-84.
7. Crowley J.T., Toledo A.M., LaRocca T.J., Coleman J.L., London E., Benach J.L. Lipid exchange between Borrelia burgdorferi and host cells. PLoS Pathog 2013, 9:e1003109.
8. Larocca T.J., Pathak P., Chiantia S., Toledo A., Silvius J.R., Benach J.L., London E. Proving lipid rafts exist: membrane domains in the prokaryote Borrelia burgdorferi have the same properties as eukaryotic lipid rafts. PLoS Pathog 2013, 9:e1003353.
9. Gilk S.D., Cockrell D.C., Luterbach C., Hansen B., Knodler L.A., Ibarra J.A., Steele-Mortimer O., Heinzen R.A. Bacterial colonization of host cells in the absence of cholesterol. PLoS Pathog 2013, 9:e1003107.
10. Santos A.J., Meinecke M., Fessler M.B., Holden D.W., Boucrot E. Preferential invasion of mitotic cells by Salmonella reveals that cell surface cholesterol is maximal during metaphase. J Cell Sci 2013, 126:2990-2996.
11. Mounier J., Boncompain G., Senerovic L., Lagache T., ChrÈtien F., Perez F., Kolbe M., Olivo-Marin J.-C., Sansonetti P.J., Sauvonnet N. Shigella effector IpaB-induced cholesterol relocation disrupts the golgi complex and recycling network to inhibit host cell secretion. Cell Host Microbe 2012, 12:381-389.
12. Burnaevskiy N., Fox T.G., Plymire D.A., Ertelt J.M., Weigele B.A., Selyunin A.S., Way S.S., Patrie S.M., Alto N.M. Proteolytic elimination of N-myristoyl modifications by the Shigella virulence factor IpaJ. Nature 2013, 496:106-109.
13. Kim M.J., Kim M.K., Kang J.S. Involvement of lipid rafts in the budding-like exit of Orientia tsutsugamushi. Microb Pathog 2013, 63C:37-43.
14. Alix E., Mukherjee S., Roy C.R. Subversion of membrane transport pathways by vacuolar pathogens. J Cell Biol 2011, 195:943-952.
15. Weber S.S., Ragaz C., Reus K., Nyfeler Y., Hilbi H. Legionella pneumophila exploits PI(4)P to anchor secreted effector proteins to the replicative vacuole. PLoS Pathog 2006, 2:e46.
16. Hsu F.S., Zhu W.H., Brennan L., Tao L.L., Luo Z.Q., Mao Y.X. Structural basis for substrate recognition by a unique Legionella phosphoinositide phosphatase. Proc Natl Acad Sci U S A 2012, 109:13567-13572.
17. Norris F.A., Wilson M.P., Wallis T.S., Galyov E.E., Majerus P.W. SopB a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase. Proc Natl Acad Sci U S A 1998, 95:14057-14059.
18. Mallo G.V., Espina M., Smith A.C., Terebiznik M.R., Aleman A., Finlay B.B., Rameh L.E., Grinstein S., Brumell J.H. SopB promotes phosphatidylinositol 3-phosphate formation on Salmonella vacuoles by recruiting Rab5 and Vps34. J Cell Biol 2008, 182:741-752.
19. Rogers L.D., Brown N.F., Fang Y., Pelech S., Foster L.J. Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events. Sci Signal 2011, 4:rs9.
20. Tahoun A., Mahajan S., Paxton E., Malterer G., Donaldson D.S., Wang D., Tan A., Gillespie T.L., O'Shea M., Roe A.J., et al. Salmonella transforms follicle-associated epithelial cells into M cells to promote intestinal invasion. Cell Host Microbe 2012, 12:645-656.
21. Viner R., Chetrit D., Ehrlich M., Segal G. Identification of two Legionella pneumophila effectors that manipulate host phospholipids biosynthesis. PLoS Pathog 2012, 8:e1002988.
22. Mital J., Miller N.J., Fischer E.R., Hackstadt T. Specific chlamydial inclusion membrane proteins associate with active Src family kinases in microdomains that interact with the host microtubule network. Cell Microbiol 2010, 12:1235.
23. Elwell C.A., Engel J.N. Lipid acquisition by intracellular Chlamydiae. Cellular Microbiol 2012, 14:1010-1018.
24. Cocchiaro J.L., Kumar Y., Fischer E.R., Hackstadt T., Valdivia R.H. Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole. Proc Natl Acad Sci U S A 2008, 105:9379-9384.
25. Melo R.C.N., Dvorak A.M. Lipid body-phagosome interaction in macrophages during infectious diseases: host defense or pathogen survival strategy?. PLoS Pathog 2012, 8:e1002729.
26. Saka H.A., Valdivia R. Emerging roles for lipid droplets in immunity and host-pathogen interactions. Annu Rev Cell Dev Biol 2012, 28:411-437.
27. Xiong Q., Rikihisa Y. Subversion of NPC1 pathway of cholesterol transport by Anaplasma phagocytophilum. Cell Microbiol 2012, 14:560-576.
28. O'Brien D.K., Melville S.B. Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues. Infect Immun 2004, 72:5204-5215.
29. Creasey E.A., Isberg R.R. The protein SdhA maintains the integrity of the Legionella-containing vacuole. Proc Natl Acad Sci U S A 2012, 109:3481-3486.
30. Simeone R., Bobard A., Lippmann J., Bitter W., Majlessi L., Brosch R., Enninga J. Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death. PLoS Pathog 2012, 8:e1002507.
31. Sitkiewicz I., Stockbauer K.E., Musser J.M. Secreted bacterial phospholipase A2 enzymes: better living through phospholipolysis. Trends Microbiol 2007, 15:63-69.
32. Russell A.B., LeRoux M., Hathazi K., Agnello D.M., Ishikawa T., Wiggins P.A., Wai S.N., Mougous J.D. Diverse type VI secretion phospholipases are functionally plastic antibacterial effectors. Nature 2013, 496:508-512.
33. Lee W., VanderVen B.C., Fahey R.J., Russell D.G. Intracellular Mycobacterium tuberculosis exploits host-derived fatty acids to limit metabolic stress. J Biol Chem 2013, 288:6788-6800.
34. Son M.S., Matthews W.J., Kang Y., Nguyen D.T., Hoang T.T. In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Infect Immun 2007, 75:5313-5324.
35. Krivan H.C., Franklin D.P., Wang W., Laux D.C., Cohen P.S. Phosphatidylserine found in intestinal mucus serves as a sole source of carbon and nitrogen for salmonellae and Escherichia coli. Infect Immun 1992, 60:3943-3946.
36. Pride A.C., Herrera C.M., Guan Z., Giles D.K., Trent M.S. The outer surface lipoprotein VolA mediates utilization of exogenous lipids by Vibrio cholerae. mBio 2013, 4:e00305-e00313.
37. Pandey A.K., Sassetti C.M. Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci U S A 2008, 105:4376-4380.
38. Daniel J., Maamar H., Deb C., Sirakova T.D., Kolattukudy P.E. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS Pathog 2011, 7:e1002093.
39. Singh V., Jamwal S., Jain R., Verma P., Gokhale R., Rao K.V.S. Mycobacterium tuberculosis-driven targeted recalibration of macrophage lipid homeostasis promotes the foamy phenotype. Cell Host Microbe 2012, 12:669-681.
40. Howe D., Heinzen R.A. Coxiella burnetii inhabits a cholesterol-rich vacuole and influences cellular cholesterol metabolism. Cell Microbiol 2006, 8:496-507.
41. Roca F.J., Ramakrishnan L. TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species. Cell 2013, 153:521-534.
42. Jackson S.K., Stark J.M., Taylor S., Harwood J.L. Changes in phospholipid fatty acid composition and triacylglycerol content in mouse tissues after infection with bacille Calmette-Guerin. Br J Exp Pathol 1989, 70:435-441.
43. Semova I., Carten J.D., Stombaugh J., Mackey L.C., Knight R., Farber S.A., Rawls J.F. Microbiota regulate intestinal absorption and metabolism of fatty acids in the zebrafish. Cell Host Microbe 2012, 12:277-288.
44. Ghosh J., Bose M., Roy S., Bhattacharyya S.N. Leishmania donovani targets Dicer1 to downregulate miR-122, lower serum cholesterol, and facilitate murine liver infection. Cell Host Microbe 2013, 13:277-288.
45. Lin M., Rikihisa Y. Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival. Infect Immun 2003, 71:5324-5331.
46. Arellano-Reynoso B., Lapaque N., Salcedo S., Briones G., Ciocchini A.E., Ugalde R., Moreno E., Moriyon I., Gorvel J.P. Cyclic beta-1,2-glucan is a Brucella virulence factor required for intracellular survival. Nat Immunol 2005, 6:618-625.
47. Livermore B.P., Bey R.F., Johnson R.C. Lipid metabolism of Borrelia hermsi. Infect Immun 1978, 20:215-220.
48. Schroder N.W., Schombel U., Heine H., Gobel U.B., Zahringer U., Schumann R.R. Acylated cholesteryl galactoside as a novel immunogenic motif in Borrelia burgdorferi sensu stricto. J Biol Chem 2003, 278:33645-33653.
49. Hackstadt T., Scidmore M.A., Rockey D.D. Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci U S A 1995, 92:4877-4881.
50. Hackstadt T., Rockey D.D., Heinzen R.A., Scidmore M.A. Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J 1996, 15:964-977.
51. Derre I., Swiss R., Agaisse H. The lipid transfer protein CERT interacts with the Chlamydia inclusion protein IncD and participates to ER-Chlamydia inclusion membrane contact sites. PLoS Pathog 2011, 7:e1002092.
52. Elwell C.A., Jiang S., Kim J.H., Lee A., Wittmann T., Hanada K., Melancon P., Engel J.N. Chlamydia trachomatis co-opts GBF1 and CERT to acquire host sphingomyelin for distinct roles during intracellular development. PLoS Pathog 2011, 7:e1002198.
53. Cox J.V., Naher N., Abdelrahman Y.M., Belland R.J. Host HDL biogenesis machinery is recruited to the inclusion of Chlamydia trachomatis-infected cells and regulates chlamydial growth. Cell Microbiol 2012, 14:1497-1512.
54. Hatch G.M., McClarty G. Phospholipid composition of purified Chlamydia trachomatis mimics that of the eucaryotic host cell. Infect Immun 1998, 66:3727-3735.
55. Carabeo R.A., Mead D.J., Hackstadt T. Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion. Proc Natl Acad Sci U S A 2003, 100:6771-6776.
56. Haque M., Hirai Y., Yokota K., Mori N., Jahan I., Ito H., Hotta H., Yano I., Kanemasa Y., Oguma K. Lipid profile of Helicobacter spp.: presence of cholesteryl glucoside as a characteristic feature. J Bacteriol 1996, 178:2065-2070.
57. Testerman T.L., McGee D.J., Mobley H.L. Helicobacter pylori growth and urease detection in the chemically defined medium Ham's F-12 nutrient mixture. J Clin Microbiol 2001, 39:3842-3850.
58. de Chastellier C., Thilo L. Cholesterol depletion in Mycobacterium avium-infected macrophages overcomes the block in phagosome maturation and leads to the reversible sequestration of viable mycobacteria in phagolysosome-derived autophagic vacuoles. Cell Microbiol 2006, 8:242-256.
59. Layre E., Sweet L., Hong S., Madigan C.A., Desjardins D., Young D.C., Cheng T.-Y., Annand J.W., Kim K., Shamputa I.C., et al. A comparative lipidomics platform for chemotaxonomic analysis of Mycobacterium tuberculosis. Chem Biol 2011, 18:1537-1549.
60. Salman M., Rottem S. The cell membrane of Mycoplasma penetrans: lipid composition and phospholipase A1 activity. Biochim Biophys Acta 1995, 1235:369-377.
61. Zeiman E., Tarshis M., Rottem S. Mycoplasma penetrans under nutritional stress: influence on lipid and lipoprotein profiles and on the binding to and invasion of HeLa cells. FEMS Microbiol Lett 2008, 287:243-249.
62. Catron D.M., Sylvester M.D., Lange Y., Kadekoppala M., Jones B.D., Monack D.M., Falkow S., Haldar K. The Salmonella-containing vacuole is a major site of intracellular cholesterol accumulation and recruits the GPI-anchored protein CD55. Cell Microbiol 2002, 4:315-328.
63. Catron D.M., Lange Y., Borensztajn J., Sylvester M.D., Jones B.D., Haldar K. Salmonella enterica serovar Typhimurium requires nonsterol precursors of the cholesterol biosynthetic pathway for intracellular proliferation. Infect Immun 2004, 72:1036-1042.